Legend Biotech Q4 EPS $(0.30) Down From $(0.22) YoY, Sales $39.00M Down From $40.78M YoY

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.30) per share. This is a 36.36 percent decrease over losses of $(0.22) per share from the same period last year. The company reported $39.00 million in sales

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.30) per share. This is a 36.36 percent decrease over losses of $(0.22) per share from the same period last year. The company reported $39.00 million in sales this quarter. This is a 4.37 percent decrease over sales of $40.78 million the same period last year.

Total
0
Shares
Related Posts
Read More

Recap: Oscar Health Q1 Earnings

Oscar Health (NYSE:OSCR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Oscar Health missed estimated earnings by 71.43%, reporting an EPS of $-0.36 versus an estimate of $-0.21.

OSCR